New DOJ Task Force Announced Will Impact Health Care Providers & Prescribers in Northern New England

June 29, 2022 Alerts and Newsletters

Major enforcement news was released today, Wednesday, June 29, 2022, for medical professionals and anyone working in or around the health care space in Maine, New Hampshire, and Vermont.

The United States Department of Justice (DOJ) announced the formation of a new "Strike Force" to investigate physicians, pharmacists and medical professionals related to allegations of health care fraud and diversion in New Hampshire, Maine, and Vermont. The task force will contain representatives from United States Attorney’s Offices in Maine, New Hampshire, and Vermont, as well as the Health Care Fraud Unit in the Criminal Division’s Fraud Section based in Washington, D.C., and law enforcement partners at the U.S. Department of Health and Human Services Office of the Inspector General (HHS-OIG), U.S. Drug Enforcement Administration (DEA), and the Federal Bureau of Investigation (FBI).

This regional strike force model has been used by the DOJ in other jurisdictions, which resulted in significant enforcement activity – mostly against providers – including investigations, prosecutions, and seizure of assets.

Unfortunately, if history is a guide, the government’s investigations may go beyond intentional wrongdoers and may sadly extend to other legitimate businesses operating in this space and doing nothing untoward.

The Northern New England task force will be eager to demonstrate its prowess in the region in the near term. The task force will likely harness a robust in-house data analytics team to evaluate prescribing practices, including evaluating outliers. The task force’s presence will likely also lead to an increased focus on state and federal false claims act investigations.

Now is a good time for providers and prescribers to review record keeping and compliance practices.

Relatedly, this week in Xiulu Ruan v. United States, the Supreme Court clarified and strengthened the amount and type of proof required to convict a prescriber of distributing controlled substances for other than a legitimate medical purpose or outside the usual course of professional medical practice. Now, the government must face the tough task of proving beyond a reasonable doubt that a prescriber knowingly or intentionally acted in an unauthorized manner when making a medical decision. A good defense team will need to understand Ruan and its likely effect on false claims act litigation and criminal prosecutions.

Verrill has a team of seasoned White-Collar Defense, Trial, and Health Care lawyers in Maine, Massachusetts, and Connecticut, including a former senior DOJ lawyer who pioneered opioid prosecutions for the government and worked closely with the Strike Force model in other jurisdictions. Our robust and multi-disciplinary team understands how the DOJ may go about building, assessing, and prosecuting these cases.

For more information on how to prepare for, or respond to, any government interaction, or if you are contacted by a member of law enforcement, please contact Verrill Partner David Lazarus or another member of Verrill’s team.

Firm Highlights

Publication/Podcast

Hospitals Win 340B Medicare Rate Cut Suit, But When, How, and How Much They Will Recoup Remains Unclear

In a recent unanimous decision, the Supreme Court found that the Centers for Medicare and Medicaid Services (“CMS”), part of the federal Department of Health and Human Services (“HHS”), erred when it significantly reduced...

Publication/Podcast

James Roosevelt, Jr. Published in ScienceDirect

Verrill attorney James Roosevelt Jr. was published in the February 2022 volume of ScienceDirect , a scientific, technical, and medical research publication. His article “A Federal Indian Health Insurance Plan: Fulfilling a Solemn Obligation...

Publication/Podcast

What's Notable In DOJ's 1st Cyber-Fraud Initiative Settlement

Verrill attorneys David G. Lazarus , Michael K. Fee , and Jeffrey Smagula recently wrote the article "What's Notable In DOJ's 1st Cyber-Fraud Initiative Settlement" published in Law360 . The article reviews the U.S...

Matter

Patent Litigation: Electronic Health Records

Defended electronic health record (“EHR”) software producer in patent dispute involving a non-practicing entity and patents related to database design and operation. Filed an early motion to dismiss based upon subject matter eligibility under...

Publication/Podcast

2021 Medicare Cost Report Preparation, Reminders and New Developments for Hospitals

Publication/Podcast

Early Asset Forfeiture Is Key Part Of Criminal Defense Plans

Verrill attorney David Lazarus was recently published in Law360 for his article "Early Asset Forfeiture Is Key Part Of Criminal Defense Plans." In the article Lazarus explains "asset forfeiture is a component of almost...

Publication/Podcast

How Growing Cyber Scrutiny Affects Corporate Compliance

Verrill attorneys David Lazarus , Michael Fee , and Jeffery Smagula authored an article published in Law360 on December 3, 2021 entitled "How Growing Cyber Scrutiny Affects Corporate Compliance." In the article Lazarus, Fee...

News

Verrill Partner Robert Ruesch Elected to American Bar Association’s Forum on Construction Law’s Governing Committee

News

31 Verrill Attorneys, Across Four Offices, Recognized in 2022 Chambers & Partners Guide

Matter

Patent Litigation: Medical Device

Defended company medical device manufacturer against claimed infringement of expired patent relating to laser hair removal; obtained stay of matter pending reexamination of patent, which resulted in cancelling of all allegedly infringing claims and...

Contact Verrill at (855) 307 0700